Health & Life Sciences

News

Theodore M. Sullivan quoted in article “Medical Device Makers Urged to Beef Up Product Cybersecurity”

Bloomberg BNA

Below is an excerpt:

Many in the device industry have urged the FDA to clarify when manufacturers need to notify the agency about software updates that seek to strengthen a product’s cybersecurity, which are constantly evolving based on new information and technology. Some changes made to bolster a device’s cybersecurity could require manufacturers to seek a new market clearance or approval from the FDA, which can be costly and time consuming.

The document should be good for industry, Theodore Sullivan, a Washington-based attorney at Quarles & Brady LLP, told Bloomberg BNA Dec. 27. “It is a pretty common-sense guidance that recognizes the value of permitting correction of most cybersecurity vulnerabilities without undue burdensome reporting requirements.”

Originally published in Bloomberg BNA, December 28, 2016

We have updated our Privacy Policy. Please click here to view our new policy.